Celgene

Activities: Research & Development Pharmaceutical

Trending Articles

  1. Ardena acquires Catalent's US oral dose manufacturing facility, adding further bioanalytical services The CRO/CDMO will now integrate its advanced late-stage and small-scale commercial oral drug product manufacturing services with an extended list of bioanalytical services,...
  2. Jabil acquires CDMO Pharmaceutics International Pii's aseptic filling, lyophilisation and oral solid dose manufacturing capabilities will significantly bolster Jabil's pharmaceutical solutions offering
  3. Guardtech encourage new clients to book ‘game-changing’ visit to their Cleancube Showroom Suffolk-based firm have thrown open the doors of their award-winning shipping container solution to show Life Sciences firms what the fuss is all about
  4. How is generative AI driving value in the life sciences sector? Generative AI has the potential to expedite clinical discovery and to streamline timely processes
  5. Eleva partners with 3PBIOVAN to boost the GMP manufacturing capacity of its pipeline programmes The collaboration will almost triple Eleva's GMP biologics production capacity, allowing the company to further advance its dry AMD and C3G-focused clinical pipeline

Upcoming event

Pharma Packaging and Labelling Forum

5–6 March 2025 | Conference | San Diego, US See all

Related Content

Design & Build

ISPE names Facility of the Year 2019

Six winners in seven categories recognising innovation and creativity in manufacturing facilities serving the regulated healthcare industry
Media

BMS' acquisition of Celgene could position the company amongst top five most profitable pharma giants

Following the Bristol-Myers Squibb (BMS) announcement on 3 January 2019 that it will acquire Celgene in a cash and stock deal with an equity value of approximately $74 billion, Edit Kovalcsik, Managing Pharma Analyst at GlobalData, offers her view on this significant merger
Finance

Bristol-Myers Squibb to merge with Celgene in multimillion deal

Transaction will see a combined pharmaceutical company in pole position within the immuno-oncology and the treatment of blood cancers market
Media

GlobalData publishes analysis of top 25 global pharma companies

The data and analytics company has tracked the market cap performance of the top 25 pharma companies for the quarter ending 31 March, 2018 compared to 2017 revealing a number of interesting insights
Media

Vanderbilt University Medical Center launches Nashville Biosciences

The subsidiary will enable pharmaceutical and other life science companies to leverage the wealth of data contained within the Medical Center’s genomics and health information technology resources, to accelerate drug discovery and development
Media

GlobalData names top 25 global pharma companies by market cap

The performance highlights of the top 25 publicly traded global pharma companies for the year 2017 have been confirmed in the latest research from GlobalData
Media

Celgene set to become leader in CAR-T space

According to GlobalData, a data and analytics company, Celgene’s acquisition of Juno Therapeutics puts the company in a good position to be a frontrunner in the chimeric antigen receptor-T cell space
Subscribe now